Comparison of patients admitted to an inner-city intensive care unit across 3 COVID-19 waves

Sindhaghatta Venkatram1, Arundhati Dileep2, Ked Fortuzi3

  • 1Associate Professor of Clinical Medicine, Division of Pulmonary and Critical Care Medicine, BronxCare Health System, Bronx, NY, USA.

Medicine
|February 24, 2023
PubMed

Insights

COVID-19 outcomes in inner-city ICU patients improved over three waves, with decreased mortality and better discharge rates. Mechanical ventilation and length of stay were lower in the initial wave.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Inner-city populations face disproportionately high COVID-19 mortality.
  • Limited data exists on COVID-19 outcomes in inner-city intensive care units (ICUs) across multiple infection waves.

Purpose of the Study:

  • To analyze COVID-19 outcomes in an inner-city ICU over three distinct infection waves.
  • To identify changes in mortality, length of stay, mechanical ventilation use, and discharge disposition.

Main Methods:

  • Retrospective study of 716 patients admitted to an ICU in Bronx, NY, from March 2020 to February 2022.
  • Comparison of outcomes across three COVID-19 waves.
  • Analysis of in-hospital mortality, length of stay, mechanical ventilation, and discharge disposition.

Main Results:

  • In-hospital mortality decreased significantly from 57% in the first wave to 37% in the third wave (P < .001).
  • Length of stay and mechanical ventilation days were lower in the first wave.
  • Improved discharge disposition observed in later waves, with more patients discharged directly home.

Conclusions:

  • Inner-city COVID-19 patient outcomes, including mortality and discharge disposition, showed significant improvement across successive infection waves.
  • Factors predicting mortality included age, male gender, COPD, shock, acute kidney injury, dialysis, and mechanical ventilation.
  • These findings are encouraging given the historically high COVID-19 mortality risk in this demographic.

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
251
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
312
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
274
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
178
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
188
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
328